Display options
Cite
Adami GF, Gandolfo P, Esposito M, et al. Orally-administered Serum Ranitidine Concentration after Biliopancreatic Diversion for Obesity. Obes Surg. 1991;1(3):293-294doi: 10.1381/096089291765561024.
Adami, G. F., Gandolfo, P., Esposito, M., & Scopinaro, N. (1991). Orally-administered Serum Ranitidine Concentration after Biliopancreatic Diversion for Obesity. Obesity surgery, 1(3), 293-294. https://doi.org/10.1381/096089291765561024
Adami, et al. "Orally-administered Serum Ranitidine Concentration after Biliopancreatic Diversion for Obesity." Obesity surgery vol. 1,3 (1991): 293-294. doi: https://doi.org/10.1381/096089291765561024
Adami GF, Gandolfo P, Esposito M, Scopinaro N. Orally-administered Serum Ranitidine Concentration after Biliopancreatic Diversion for Obesity. Obes Surg. 1991 Sep;1(3):293-294. doi: 10.1381/096089291765561024. PMID: 10775927.
Copy Download .nbib Format: NLM
Share it on

Obes Surg. 1991 Sep;1(3):293-294. doi: 10.1381/096089291765561024.

Orally-administered Serum Ranitidine Concentration after Biliopancreatic Diversion for Obesity.

Obesity surgery

Adami, Gandolfo, Esposito, Scopinaro

Affiliations

  1. Istituto di Clinica Chirurgica, University of Genoa, Genova 16132 Italy.

PMID: 10775927 DOI: 10.1381/096089291765561024

Abstract

Stomal ulcer occurs in about 5% of patients after biliopancreatic diversion (BPD). Seven females were given 150 or 300 mg of ranitidine orally. Blood samples found a pharmacologically effective concentration from 0.5 to 8 h after both doses. Intestinal absorption of ranitidine is maintained after BPD.

Publication Types